This section is being updated. Be sure to check back soon for an updated list of enrolling and soon to be enrolling clinical trials.
Phase 2 study of VX-152 combination drug in people with cystic fibrosis (Vertex VX-152-102)
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
Phase 2 study of inhaled nitric oxide in people with CF (Novoteris NO-CF-02E)
Phase 1b study of inhaled AZD5634 in adults with CF (AstraZeneca D6600C00002)
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients
PTI: A Phase I Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects with Cystic Fibrosis with any mutation.
Abbvie: Long-Term Study In U.S. Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonpathy)
Bayer: Early Signs of Efficacy Study with Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
Role of Glucagon in Glucose Control in Cystic Fibrosis Related Diabetes
PET Assessment of Acute of Lung Transplant Rejection
Redox Imbalance and the Development of CF Related Diabetes (RedoxyMeal)
Effect of Chronic Incretin-Based Therapy in CF (CF Related Diabetes Study)
Blood Flow and Vascular Function in CF (Exercise, Blood Flow & Artery Function):
Gender Disparity and Hormones in CF (Investigating Impact of Hormones in CF):